AVITA Raises 2026 Revenue Guidance Again After Quarterly Sales Jump
AVH: $4.55 -1.73% · MC: $778M
AVITA Medical lifted its 2026 revenue forecast for a second time, to approximately $92 million–$94 million, from $86 million–$89 million, after third-quarter revenue rose 53% year on year and 20% from the previous quarter. It reaffirmed its expectation of cash-flow breakeven in the fourth quarter; separately, Medicare finalized national physician payment valuations and a simpler billing-code structure for RECELL procedures from 2027.

Comments